TP53 and cancer: This effect was explained by the finding that the E6 oncoprotein from high-risk mucosal human papillomaviruses (HPVs) causes more efficient degradation of the Arg form of the p53 protein than of the Pro form, thus reducing cellular levels of p53 protein and increasing the risk of HPV-associated cancers in TP53-Arg homozygotes [7].